OOIR: Observatory of International Research

Papers

(The TQCC of Progress in Retinal and Eye Research is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Heparan sulfate proteoglycans (HSPGs) of the ocular lens	340
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	231
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments	185
Clinical vision and molecular loss: Integrating visual psychophysics with molecular genetics reveals key details of normal and abnormal visual processing	182
In vivo application of base and prime editing to treat inherited retinal diseases	178
Editorial Board	172
Editorial Board	167
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	126
Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology	115
Cell identity changes in ocular surface Epithelia	106
The genetics and disease mechanisms of rhegmatogenous retinal detachment	102
Toward an internationally accepted standard for reading charts	100
Editorial Board	96
Posterior capsule opacification: What's in the bag?	95
IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors	95
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	91
Cellular component transfer between photoreceptor cells of the retina	87
Standard automated perimetry for glaucoma and diseases of the retina and visual pathways: Current and future perspectives	82
Role of glia in optic nerve	80
Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling	78
Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches	77
Early and late stage gene therapy interventions for inherited retinal degenerations	77
Pathogenesis of ocular toxoplasmosis	72
Rhodopsin, light-sensor of vision	71
Optical coherence tomography angiography in diabetic retinopathy	71

The innate immune system in diabetic retinopathy	69
Inflammation in Glaucoma: From the back to the front of the eye, and beyond	69
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	69
Retinal pigment epithelium 65 kDa protein (RPE65): An update	67
Crosslinking with UV-A and riboflavin in progressive keratoconus: From laboratory to clinical practice – Developments over 25 years	67
A reinterpretation of critical flicker-frequency (CFF) data reveals key details about light adaptation and normal and abnormal visual processing	64
Alzheimer's disease pathophysiology in the Retina	64
Editorial Board	62
Editorial Board	62
Editorial Board	60
Editorial Board	60
Corneal endothelial dysfunction: Evolving understanding and treatment options	58
It is time for a moonshot to find “Cures” for diabetic retinal disease	58
Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA)	57
Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration	56
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	53
Modeling complex age-related eye disease	52
Non-vasogenic cystoid maculopathies	51
Editorial Board	50
Corneal cross-linking	49
pH in the vertebrate retina and its naturally occurring and pathological changes	49
Recent understanding of binocular vision in the natural environment with clinical implications	48
Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO)	47
Reticular pseudodrusen: A critical phenotype in age-related macular degeneration	47
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma	47
Immunological aspects of RPE cell transplantation	46
Regulation of lens water content: Effects on the physiological optics of the lens	46
Shedding light on myopia by studying complete congenital stationary night blindness	45
Pathobiology of the crystalline lens in Stickler syndrome	45
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	44
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	44
The two-faced effects of nerves and neuropeptides in corneal diseases	44
Implications of genetic variation in the complement system in age-related macular degeneration	43
The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies	43
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	43
Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms	42